<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-id journal-id-type="publisher-id">KJIM</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>The Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23682231</article-id>
      <article-id pub-id-type="pmc">3654135</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2013.28.3.356</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synephrine-containing dietary supplement precipitating apical ballooning syndrome in a young female</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chung</surname>
            <given-names>Hyemoon</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>Sung Woo</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Tae Hoon</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoon</surname>
            <given-names>Ji Hyun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Dae Won</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Yoo Mi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Hong</surname>
            <given-names>Bum-Kee</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Division of Cardiology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.</aff>
      <aff id="A3"><label>3</label>Department of Radiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Correspondence to Bum-Kee Hong, M.D. Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea. Tel: +82-2-2019-3311, Fax: +82-2-3463-3463, <email>bkhong@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>5</month>
        <year>2013</year>
      </pub-date>
      <volume>28</volume>
      <issue>3</issue>
      <fpage>356</fpage>
      <lpage>360</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>15</day>
          <month>12</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>12</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Apical ballooning syndrome (ABS) is a unique reversible cardiomyopathy that is frequently precipitated by emotional or physical stress. In addition, the few drugs reported to precipitate ABS were either illegal or strictly controlled for medical use. This paper reports a case of ABS precipitated by a dietary supplement. Our case accentuates the potential risk of dietary supplements containing synephrine, which is uncontrolled and available to the general public. Therefore, the Korea Food and Drug Administration should regulate these dietary supplements, and warn healthcare workers and the general public of the potential hazards of the indiscriminate abuse of dietary supplements.</p>
      </abstract>
      <kwd-group>
        <kwd>Takotsubo cardiomyopathy</kwd>
        <kwd>Dietary supplements</kwd>
        <kwd>Synephrine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Apical ballooning syndrome (ABS), also called stress-induced cardiomyopathy or Takotsubo cardiomyopathy, is characterized by transient akinesis from the apical to midventricular segments and hyperkinesis of the basal segments, with markedly reduced left ventricular systolic function [<xref ref-type="bibr" rid="B1">1</xref>]. ABS mimics acute coronary syndrome, since electrocardiography often reveals ST-segment elevation with mild elevation of cardiac biomarkers [<xref ref-type="bibr" rid="B2">2</xref>]. Generally, ABS is triggered by severe emotional or physical stress [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. In addition, some drugs can precipitate the development of ABS. However, the drugs reported to trigger ABS were either illegal or strictly controlled for medical use [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. By contrast, this paper reports a case of ABS precipitated by dietary supplements, which are not controlled and available to the general public.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 21-year-old female presented to the emergency room with disturbed consciousness and a seizure. She had no relevant medical history. She had been taking dietary supplements purchased via the internet for the proceeding week in order to lose weight. The supplements contained caffeine and synephrine. The physical examination revealed a blood pressure of 115/84 mmHg and pulse of 110 beats per minute. On auscultation, the lungs were clear and heart sounds normal, with no murmur or gallop. The 12-lead electrocardiograph revealed sinus tachycardia, T wave inversion in leads II, III, aVF, and V3-6, and a prolonged QTc interval of 537 ms (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Laboratory analysis revealed creatine kinase (CK) 374 U/L (normal range, 21 to 215), CK-MB 9.9 ng/mL (normal range, &lt; 4.3), troponin I 0.59 ng/mL (normal range, &lt; 0.07), brain natriuretic peptide 734 pg/mL (normal range, &lt; 100), and C-reactive protein 3.6 mg/L (normal range, 0.1 to 6.0). The serum catecholamine levels measured 3 days after admission showed dopamine 6.03 ng/mL (normal range, 0.5 to 6.2), epinephrine 0.03 ng/mL (normal range, &lt; 0.3), and norepinephrine 0.48 ng/mL (normal range, &lt; 0.8). Transthoracic echocardiography (TTE) performed at the day of admission showed apical ballooning of the left ventricle due to akinesis from the apical to midventricular segments, and hyperkinesis of the basal segments, with a markedly reduced left ventricular ejection fraction of 28% (<xref ref-type="fig" rid="F2">Fig. 2</xref>). The impairment extended across the coronary artery distribution. Cardiac magnetic resonance (CMR) was performed 2 days after admission. The cine CMR findings were consistent with TTE (<xref ref-type="fig" rid="F3">Fig. 3A and 3B</xref>) and the late enhancement CMR revealed no late gadolinium enhancement (<xref ref-type="fig" rid="F3">Fig. 3C</xref>). In addition, reconstructed CMR images of the coronary arteries revealed no significant stenosis (<xref ref-type="fig" rid="F3">Fig. 3D and 3E</xref>). Under a working diagnosis of ABS, she was treated conservatively with a &#x3B2;-blocker, angiotensin converting enzyme inhibitor, and loop diuretics. Gradually, her symptoms improved. Another TTE performed 9 days after admission revealed a normal ejection fraction of 63%, with complete recovery of the apical and midventricular wall motion. While hospitalized, neurological evaluations including electroencephalography and brain magnetic resonance imaging were performed to determine whether epilepsy was the cause of her seizure. However, there was no definite evidence of epilepsy or other organic brain abnormalities. Therefore, she was not given any antiepileptic medication. She remained stable clinically and hemodynamically for 10 days of hospitalization and was discharged home without cardiological or neurological sequelae. In the year since, there has been no recurrence of ABS or seizures.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Besides severe emotional or physical stress, drugs can precipitate ABS. However, the drugs reported to trigger ABS, such as dobutamine, epinephrine, and amphetamine, are either illegal or strictly controlled for medical use in many countries [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. In contrast, this paper reports a case of ABS precipitated by dietary supplements that are freely available to the general public.</p>
      <p>In 2004, the United States Food and Drug Administration determined that ephedra and ephedrine-containing dietary supplements were unsafe for unregulated use and banned their sale. However, this ban does not preclude the use of other structurally related sympathomimetic amines in products for weight reduction. Consequently, synephrine has emerged as an alternative to ephedra in dietary supplements and is listed often as "extract of <italic>Citrus aurantium</italic>" or "extract of bitter orange." Synephrine is a sympathomimetic amine derived from <italic>C. aurantium</italic> and shares structural similarities with other sympathomimetic phenylethylamine drugs, such as ephedrine, amphetamine, and phenylpropanolamine. Although synephrine is considered safe compared to ephedra, the toxicity of this substance is largely unknown, especially in combination with caffeine, which potentiates the cardiovascular effects of other sympathomimetic agents. In addition, severe adverse cardiovascular side effects of synephrine-containing dietary supplements have been reported [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. To our knowledge, this is the first report of ABS precipitated by synephrine-containing dietary supplements.</p>
      <p>The pathophysiology of ABS remains poorly understood. Several hypotheses have been proposed as the mechanisms of ABS, including direct catecholamine-induced cardiomyocyte injury via intracellular calcium overload, and an indirect effect of a catecholamine surge resulting in epicardial spasm, microvascular dysfunction, or dynamic left ventricular outflow obstruction due to hyperkinesis of the basal segments [<xref ref-type="bibr" rid="B9">9</xref>]. Further studies are needed to clarify the pathophysiological mechanism of ABS.</p>
      <p>In conclusion, our case accentuates the potential risk of dietary supplements containing synephrine, a sympathomimetic similar to ephedra. Currently, the use of these dietary supplements is uncontrolled and they are freely available to the general public. The Korea Food and Drug Administration should take a stronger position regarding the regulation of these dietary supplements, and warn healthcare workers and the general public to be aware of the potential hazard of the indiscriminate abuse of dietary supplements.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflict of interest relevant to this article is reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Youn</surname>
              <given-names>YJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical characteristics and prognostic factors of stress-induced cardiomyopathy</article-title>
          <source>Korean Circ J</source>
          <year>2010</year>
          <volume>40</volume>
          <fpage>277</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="pmid">20589200</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Prasad</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lerman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rihal</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction</article-title>
          <source>Am Heart J</source>
          <year>2008</year>
          <volume>155</volume>
          <fpage>408</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="pmid">18294473</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wittstein</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>Thiemann</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neurohumoral features of myocardial stunning due to sudden emotional stress</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <fpage>539</fpage>
          <lpage>548</lpage>
          <pub-id pub-id-type="pmid">15703419</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Poh</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Diverse clinical spectrum of stress-induced cardiomyopathy</article-title>
          <source>Int J Cardiol</source>
          <year>2009</year>
          <volume>133</volume>
          <fpage>272</fpage>
          <lpage>275</lpage>
          <pub-id pub-id-type="pmid">18190984</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abraham</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mudd</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Champion</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Wittstein</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists</article-title>
          <source>J Am Coll Cardiol</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>1320</fpage>
          <lpage>1325</lpage>
          <pub-id pub-id-type="pmid">19358948</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Movahed</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Mostafizi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Reverse or inverted left ventricular apical ballooning syndrome (reverse Takotsubo cardiomyopathy) in a young woman in the setting of amphetamine use</article-title>
          <source>Echocardiography</source>
          <year>2008</year>
          <volume>25</volume>
          <fpage>429</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="pmid">18177388</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Munir</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>McIntyre</surname>
              <given-names>PZ</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature</article-title>
          <source>Tex Heart Inst J</source>
          <year>2009</year>
          <volume>36</volume>
          <fpage>586</fpage>
          <lpage>590</lpage>
          <pub-id pub-id-type="pmid">20069086</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouchard</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Howland</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Greller</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine</article-title>
          <source>Mayo Clin Proc</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>541</fpage>
          <lpage>545</lpage>
          <pub-id pub-id-type="pmid">15819293</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pilgrim</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Wyss</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <article-title>Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>124</volume>
          <fpage>283</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="pmid">17651841</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>The 12-lead electrocardiograph on admission revealed sinus tachycardia, T wave inversion in leads II, III, aVF, and V3-6, and a prolonged QTc interval of 537 ms.</p>
      </caption>
      <graphic xlink:href="kjim-28-356-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Apical four-chamber transthoracic echocardiography view during (A) diastole and (B) systole showing apical ballooning of the left ventricle due to akinesis from the apical to midventricular segments, and hyperkinesis of the basal segments with a markedly reduced left ventricular ejection fraction of 28%.</p>
      </caption>
      <graphic xlink:href="kjim-28-356-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Cine cardiac magnetic resonance (CMR) images during (A) diastole and (B) systole were consistent with transthoracic echocardiography findings. (C) Late enhancement CMR revealed no late gadolinium enhancement. Reconstructed CMR image of the (D) right and (E) left coronary arteries revealed no significant stenosis.</p>
      </caption>
      <graphic xlink:href="kjim-28-356-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
